Risk factors for cellulitis in patients with lymphedema: A case-controlled study

Lymphology

Volumn 46, Issue 3, 2013, Pages 150-156

  Teerachaisakul, M ^a   Ekataksin, W ^b   Durongwatana, S ^a   Taneepanichskul, Surasak ^a  

^a CHULALONGKORN UNIVERSITY   (Thailand)

^b MAHIDOL UNIVERSITY   (Thailand)

Author keywords

Case control; Cellulitis; Lymphedema; Risk factors

Indexed keywords

ADULT; ARTICLE; CELLULITIS; CONTROLLED STUDY; DIABETES MELLITUS; DIASTOLIC BLOOD PRESSURE; DISEASE DURATION; FEMALE; HEART RATE; HUMAN; HYPERTENSION; LYMPHEDEMA; MAJOR CLINICAL STUDY; MIDDLE AGED; OBESITY; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; SKIN ALLERGY; SYSTOLIC BLOOD PRESSURE;

CASE-CONTROL STUDIES; CELLULITIS; FEMALE; FOLLOW-UP STUDIES; HUMANS; LYMPHEDEMA; MALE; MIDDLE AGED; PROGNOSIS; RISK FACTORS;

EID: 84893654818     PISSN: 00247766     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. Witte, MH, MJ Bernas, CP Martin, et al: Lymphangiogenesis and lymphangiodysplasia: From molecular to clinical lymphology. Microsc. Res. Tech. 55 (2001), 122-145. (Pubitemid 32988912)
2. Warren, AG, H Brorson, LJ Borud, et al: Lymphedema: A comprehensive review. Ann. Plast. Surg. 59 (2007), 464.
3. Sedar, ZA, SS Akcay, A Inan, et al: Evaluation of microbial spectrum and risks factor of cellulitis in hospitalized patients. Cutan. Ocul. Toxicol. 30 (2011), 221-224.
4. Simosen, SME, ER Orman, BE Hatch, et al: Cellulitis incidence in a defined population. Epidemiol. Infect. 134 (2006), 293-299. (Pubitemid 43280237)
5. Alitalo, K, T Tammela, TV Petrova: Lymphangiogenesis in development and human disease. Nature 438 (2005), 946.
6. Angeli, V, GJ Randolph: Inflammation, lymphatic function, and dendritic cell migration. Lymphat. Res. Biol. 4 (2006), 217.
7. Ohkuma, M, E Okada: Bradykinin, PGE2, and Interleukin-6 (IL-6) Involved in pathogenesis of acute cellulitis in lymphedema. Lymphology 31 (1998), s231-232.
8. Teerachaisakul, M, W Ekataksin, S Durongwatana, et al: Diet, C-reactive protein levels and cellulitis in patients with lymphedema: a cross sectional study. J. Med. Med. Sci. 2 (2011), 1297-1301.
9. Dupuy, A, H Benchikhi, JC Roujeau: Risk factors for erysipelas of the leg (cellulitis): Case-control study. Br. Med. J. 318 (1999), 1591-1594. (Pubitemid 29267772)
10. Mokni, M, A Dupuy, M Denguezli, et al: Risk factors for erysipelas of the leg in Tunisia: A multicenter case-control study. Dermatology 212 (2006), 108-112. (Pubitemid 43260724)
11. Lewis, SD, GS Peter, O Gomez-Marin, et al: Risk factors for recurrent lower extremity cellulitis in a US veterans medical center population. Am. J. Med. Sci. 332 (2006), 304-307. (Pubitemid 46005824)
12. Karppelin, M, T Siljander, J Vuopio-Varkila, et al: Factors predisposing to acute and recurrent bacterial non- necrotizing cellulitis in hospitalized patients: a prospective case-control study. Clin. Microbiol. Infect. 16 (2010), 729-734.
13. deGodoy, JMP, PG Massari, MY Rosinha, et al: Epidemiological data and comorbidities on 428 patients hospitalized with erysipelas. Angiology 61 (2010), 492-494.
14. Shih, YCT, Y Xu, JN Cormier, et al: Incidence, treatment costs, and complications of lymphedema after breast cancer among women of working age: A 2 year follow up study. J. Clin. Oncol. 27 (2009), 2007-2014.
15. Bibas, N, H Escande, J Ofaiche, et al: Recurrent breast cellulitis associated with lymphangiectasia after tumorectomy for breast cancer. Ann. Dermatol. Venereol. 138 (2011), 508-511.
16. deGodoy, JMP, SH Silva: Prevalence of cellulitis and erysipelas in post-mastectomy patients after breast cancer. Arch. Med. Sci. 3 (2007), 249-251.
17. Hosmer, DW, S Lemeshow: Applied Logistic Regression, Second Edition. John Wiley & Sons, Inc. Canada (2000), pp 95-162.
18. Ekataksin, W, N Chanwimalueang, M Teerachaisakul: Food aggravation: Effect of dietary habits studied in 2300 patients with lymphedema. Proceedings of the 23rd International Congress of Lymphology Sep 19-23, 2011, Malmö, Sweden.
19. Ekataksin, W, N Chanwimalueang, P Piyaman, et al: Slaengh, food of animal origin can aggravate symptomatology: A clinical experience with 2,500 patients at Thailand Lymphedema Day Care Center. Proceedings of the 5th Asian Vegetarian Union Congress Nov 8-9, 2011, Hangzhou, China
20. Soria, P, A Cuest, H Romeo, et al: Dietary-treatment of lymphedema of long-chain triglycerides. Angiology 45 (1994), 703-707.
21. Shaw, C, P Mortimer, PA Judd: Randomized controlled trial comparing a low-fat diet with a weight-reduction diet in breast cancer-related lymphedema. Cancer 109 (2007), 1949-1956. (Pubitemid 46744187)
22. Damstra, RJ, MAM Steensel, JHB Boomsma, et al: Erysipelas as a sign of subclinical primary lymphoedema: a prospective quantitative scintigraphic study of 40 patients with unilateral erysipelas of the leg. Br. J. Dermatol. 158 (2008), 1210-1215. (Pubitemid 351692855)
23. Soo, JK, TA Bicanic, S Heenan, et al: Lymphatic abnormalities demonstrated by lymphoscintigraphy after lower limb cellulitis. Br. J. Dermatol. 158 (2008), 1350-1353. (Pubitemid 351692850)
24. Cox, NH: Oedema as a risk factor for multiple episodes of cellulitis/erysipelas of the lower leg: A series with community follow-up. Br. J. Dermatol. 155 (2006), 947-950.
25. Bartholomeeusen, S, J Vandenbroucke, C Truyers, et al: Epidemiology and comorbidity of erysipelas in Primary Care. Dermatology 215 (2007), 118-122. (Pubitemid 47230719)
26. Soondal, SK, MT Ahmad, S Afzal, et al: The risk factors and clinical characteristics of cellulitis: A hospital-based case-control study in Singapore. J Health Res. 23 (2009), 81-86.
27. Hinten, F, LCG Einden, JCM Hendriks, et al: Risk factors for short- and long-term complications after groin surgery in vulvar cancer. Br. J. Cancer 105 (2011), 1279-1287.
28. Ahmed, RL, KH Schmitz, AE Prizment, et al: Risk factors for lymphedema in breast cancer survivors, the Iowa women's health study. Breast Cancer Res. Treat. 130 (2011), 981-991.
29. Garcia, AM, BE Dicianno: The frequency of lymphedema in an adult spina bifida population. Am. J. Phys. Med. Rehabil. 90 (2011), 89-96.
30. Meeske, KA, JS Halley, AW Smith, et al: Risk factors for arm lymphedema following breast cancer diagnosis in black women and white women. Breast Cancer Res. Treat. 113 (2009), 383-391.
31. Machnik A, Neuhofer W, Jantsch J et al. Macrophages regulate salt-dependent volume and blood pressure by a vascular endothelial growth factor-C-dependent buffering mechanism. Nat Med. 15 (2009), 545-552.
32. Wang, Y, G Oliver: Current views on the function of the lymphatic vasculature in health and disease. Genes. Dev. 24 (2010), 2115-2126.
33. Clavin, NW, T Avraham, J Fernandez, et al: TGF-β1 is a negative regulator of lymphatic regeneration during wound repair. Am. J. Physiol. Heart Circ. Physiol. 295 (2008), 2113-2127.
34. Oka, M, C Iwata, HI Suzuki, et al: Inhibition of endogenous TGF-β signaling enhances lymphangiogenesis. Blood 111 (2008), 4571-45.
35. Mortimer, PS: Therapy approaches for lymphedema. Angiology 48 (1997), 87-91.
36. Jullien, P, J Somé, P Brantus, et al: Efficacy of home-based lymphoedema management in reducing acute attacks in subjects with lymphatic filariasis in Burkina Faso. Acta Trop. 120 (2011), S55-61.
37. Leclerc, S, A Teixeira, E Mahe, et al: Recurrent erysipelas: 47 cases. Dermatology 214 (2007), 52-57. (Pubitemid 46033001)
38. Vignes, S, A Dupuy: Recurrence of lymphoedema-associated cellulitis (erysipelas) under prophylactic antibiotic therapy: A retrospective cohort study. J. Eur. Acad. Dermatol. Venereol. 20 (2006), 818-822. (Pubitemid 44102915)